Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. - Test2 - elhamkhani - TriplyDB

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.

http://www.wikidata.org/entity/Q37204965

about

Antiepileptic drugs as prophylaxis for post-craniotomy seizures Antiepileptic drugs as prophylaxis for post-craniotomy seizures Antiepileptic drugs for treating seizures in adults with brain tumours Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis Cognition and resective surgery for diffuse infiltrative glioma: an overview Clinical Management of Seizures in Patients With Low-Grade Glioma A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors.Seizure prognosis in brain tumors: new insights and evidence-based management Questions asked and answered in pilot and feasibility randomized controlled trials.Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients.Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.Levetiracetam: a comprehensive review.Seizures in low- and high-grade gliomas: current management and future outlook.Epilepsy in the cancer patient.Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment.Placebo-corrected efficacy of modern nonenzyme-inducing AEDs for refractory focal epilepsy: systematic review and meta-analysis.Enzyme induction with antiepileptic drugs: cause for concern?Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment.Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.Levetiracetam use in the critical care setting.Treatment of epileptic seizures in brain tumors: a critical review.Peritumoral epilepsy: relating form and function for surgical success.Managing Disease and Therapy-Related Complications in Patients with Central Nervous System Tumors.Medical management for neurosurgical related seizures.Seizures in oligodendroglial tumors.Levetiracetam versus phenytoin for seizure prophylaxis in brain injured patients: a systematic review and meta-analysis.Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.Levetiracetam for seizure prevention in brain tumor patients: a systematic review.Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: A retrospective observational single center study.Neurobehavioral effects of levetiracetam in brain tumor related epilepsy.Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report.Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.Postoperative seizure control in patients with tumor-associated epilepsy.A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution.

P2860

Q24187408-A2F4AFBB-A7DB-4D1F-8E89-71F42A34F05D Q24200606-E8C99EF8-C75F-4327-9299-3FCAA6885B02 Q24234980-BC16438D-0549-42E6-8304-31E60FF16C77 Q24650880-0BD23460-6CBE-41EF-8002-1BFA8B15F743 Q26991613-47E1E09E-F38A-4291-9D4F-0AF5581842D3 Q27026254-12343FE1-4DD7-4507-AF82-1DE81B4F5C6E Q28082498-453DA71C-CB20-40A7-80FE-3AFDC76BD206 Q30435302-2854D834-D749-4A47-832E-21865E5E9442 Q33829789-0F20DB81-7F50-4764-BA2D-1458AA8B3378 Q33994043-A5A8ABF7-B046-4455-BDBF-2A968ABC9755 Q36082919-0A0A0D5B-E293-44E4-AA96-E31AB01D4D9E Q36943913-32805E2C-95DD-47F6-AB37-556B128BAA30 Q37641223-674728A8-7F15-44B7-88EB-3151C4BB01F5 Q37688063-82BAFD92-4770-453A-BE34-60F715AF91C9 Q37752365-16DD4430-67A3-4DE2-9CEB-FA226A866882 Q37838314-0BF9BD79-02D9-49C3-82DF-A7D6AB042C87 Q37968607-B5A65F34-092A-4CC3-8328-FB820FE0B882 Q37975526-C2CA2675-2278-4ECB-83B9-F0E64EB55D4B Q38046892-6AF94CAD-46C2-40A1-8240-0763E7EA2B83 Q38055317-9A50403C-F7C7-4172-A533-F7743A7D0C20 Q38055318-E78E85E8-A41A-4D88-9322-6ACFAFD20DA6 Q38105151-89F22CDC-1700-45DB-954E-9507295766C7 Q38127128-10B7BBCE-B9F5-4980-8FAE-5EB1428ABAC0 Q38132386-CD1FE27F-9E47-4003-B708-075DE642AA9C Q38206723-6F272FC6-4B7D-4DEF-8B65-C5DB60D6D9B8 Q38217449-71A31AC5-49F1-49FC-8BAA-9E8147790A96 Q38542829-FBA446CF-7E82-4F77-BDA9-784A74898C4D Q38605491-D5BE7337-44C5-48DF-937E-B648758EEA2B Q38610571-E5484A4B-EAC1-4CD7-8284-4560FBF84DD7 Q38638515-603298CA-9225-493E-994A-30132D48EA65 Q38761893-D0B6758B-32B3-4168-B5B4-78321E1656EB Q38832059-AF7D8FC6-007B-4689-A2DB-E671FBE50761 Q38962335-8063A8CC-FFD3-43BF-BE32-6360D1D8BA8F Q39378541-3DCC2E76-A767-4B24-B459-786ED99DDBFD Q41590400-FAB9618A-7ECA-409A-A03D-545FBDBD226B Q46501572-AC507D7F-201E-4D24-BBAC-E535383259C8 Q47949323-56D5C069-967A-47CD-BAEE-348E9EEAA0A8 Q48496392-35011E0D-859F-4C8F-B7C6-3CD5DF587121 Q51611368-CFE344CA-BB9E-4A51-A0BB-03F5387C731D

P2860

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.

http://www.wikidata.org/entity/Q37204965

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Safety and feasibility of swit ...... ndomized phase II pilot study.

@en

Safety and feasibility of swit ...... ndomized phase II pilot study.

@nl

type

label

Safety and feasibility of swit ...... ndomized phase II pilot study.

@en

Safety and feasibility of swit ...... ndomized phase II pilot study.

@nl

prefLabel

Safety and feasibility of swit ...... ndomized phase II pilot study.

@en

Safety and feasibility of swit ...... ndomized phase II pilot study.

@nl

P1433

Q37204965-59A93092-AD0C-49D7-855E-EF2690B7D3D4

P1476

Q37204965-8DB6A91F-DEB1-4E3E-99AB-2E10CE831183

P2093

Q37204965-15DC0DBD-23B0-4EE7-BFFD-E8911CB07265

Q37204965-1F1B2845-99C2-457E-9EBB-9CECD1950627

Q37204965-25893856-C64A-4785-8E94-F424DD7AE0B3

Q37204965-2FBD51ED-2088-459D-9084-597257BB5286

Q37204965-6A8A54A1-197B-46DE-9570-F8894AA39F13

Q37204965-7BD56C13-1664-4704-A288-D06E3A4CE326

Q37204965-B713654E-55B0-4778-B5FC-52BC2BA19A11

Q37204965-BA33C3A6-82AA-4E03-BF01-3FCAAB06FF49

Q37204965-EA3CD427-7B90-433B-8152-39A2AECF97F2

P2860

Q37204965-128A0E84-9AF1-4583-A3B7-4771877A7305

Q37204965-16D5597C-DBF3-46F6-BDE5-BAB81E80D2A9

Q37204965-2FB00239-7F62-4375-B569-2A38A93EA177

Q37204965-36FE0388-55B6-4062-83B0-B6FB12954F67

Q37204965-40062064-BC81-4EFD-BC9D-13A618919CBA

Q37204965-43DFC3CA-C408-4C71-AF9B-FBED1CB8FADE

Q37204965-53A5FEC4-DC1B-4724-A67E-F014E8541419

Q37204965-62BCB136-A86F-4360-B66B-60D910616294

Q37204965-64334F93-5211-4CBE-BD37-EB599D7C258F

Q37204965-77DE0B33-0D5E-4CC6-A501-9A2C3D3ADBE9

P2888

Q37204965-7ED3C04C-E1DB-45BB-8099-063276008CA0

P304

Q37204965-F9CACA96-DA13-44AC-9940-D1E77128453B

P31

Q37204965-06A211CF-46CA-4A5F-86D3-D1638539F9AB

P356

Q37204965-3284421D-CFCF-4EB8-8682-096D2090D0ED

P433

Q37204965-A9F0DEF8-DD8E-4777-BC1D-7A497F898C9C

P478

Q37204965-2F310F78-D408-4EAC-9E3B-2B64A2235CCB

P577

Q37204965-F887564B-5E06-4BB8-B537-BA63C283CDFA

P5875

Q37204965-237082CB-97E9-4873-8916-0BD6B0BE6E57

P698

Q37204965-18FA1F6A-329F-4D72-B120-31782F6A3841

P921

Q37204965-F8E17ED7-6BC1-4E9E-B7B0-C149EA576F3E

P932

Q37204965-0A9DEBD0-C1FC-46DC-90D2-AD915BBF7662

P356

S11060-008-9781-4

P1433

Journal of Neuro-Oncology

P1476

Safety and feasibility of swit ...... ndomized phase II pilot study.

@en

P2093

Daniel A Lim

http://www.w3.org/2001/XMLSchema#string

Edward Chang

http://www.w3.org/2001/XMLSchema#string

Kathleen R Lamborn

http://www.w3.org/2001/XMLSchema#string

Lenna Chakalian

http://www.w3.org/2001/XMLSchema#string

Marlene Burt

http://www.w3.org/2001/XMLSchema#string

Michael W McDermott

http://www.w3.org/2001/XMLSchema#string

Nicholas Barbaro

http://www.w3.org/2001/XMLSchema#string

Phiroz Tarapore

http://www.w3.org/2001/XMLSchema#string

Susan Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Levetiracetam therapy in patients with brain tumour and epilepsy.

Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy.

Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.

Efficacy, pharmacology, and adverse effects of antiepileptic drugs.

Levetiracetam: a different approach to the pharmacotherapy of epilepsy.

Clinical pharmacokinetics of levetiracetam.

Medical management of patients with brain tumors.

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.

Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

P2888

s11060-008-9781-4

P304

349-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-008-9781-4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23939939

http://www.w3.org/2001/XMLSchema#string

P698

19169651

http://www.w3.org/2001/XMLSchema#string

P921

P932

2687520

http://www.w3.org/2001/XMLSchema#string